医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
LGND · LIGAND PHARMACEUTICALS INC
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
LIGAND PHARMACEUTICALS INC（LGND）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $17.6M；高管董事有效买入 —、有效卖出 $342K。最近申报 2026-10-06。
买入 Bought—
卖出 Sold$17.6M
有效买入 Effective bought—
有效卖出 Effective sold$342K
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-10-02 | Reardon Andrew CLO & Secretary | 卖出 Sell | 5,000 | $304.07 | $1.5M | SEC |
| 2026-09-10 | Zimmermann Martine Director | 卖出 Sell · 有效 | 1,200 | $285.00 | $342K | SEC |
| 2026-09-03 | Reardon Andrew CLO & Secretary | 卖出 Sell | 5,000 | $286.09 | $1.4M | SEC |
| 2026-08-12 | Espinoza Octavio Chief Financial Officer | 卖出 Sell | 31,641 | $292.07 | $9.2M | SEC |
| 2026-08-12 | Haas Jason Director | 卖出 Sell | 7,138 | $292.81 | $2.1M | SEC |
| 2026-08-03 | Reardon Andrew CLO & Secretary | 卖出 Sell | 5,000 | $288.99 | $1.4M | SEC |
| 2026-07-01 | Reardon Andrew CLO & Secretary | 卖出 Sell | 5,000 | $313.28 | $1.6M | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-09-10 | Zimmermann Martine Director | 1,200 | $342K | |
| 2026-09-03 | Reardon Andrew Officer | 15,000 | $4.3M | 10b5-1 |
| 2026-08-12 | Espinoza Octavio Officer | 31,641 | $9.1M | 10b5-1 |
| 2026-08-12 | Haas Jason Director | 7,138 | $2.1M | |
| 2026-07-01 | Reardon Andrew Officer | 10,000 | $3.2M | 10b5-1 |
内部人 Insiders
Reardon Andrew、Zimmermann Martine、Espinoza Octavio、Haas Jason